Grant Funded Startups
Disclosed grant sizes in this feed show a clear long-tail: Syrah Resources’ $220M grant on 2022-10-20 is the largest disclosed amount, dwarfing the next ti…
Disclosed grant sizes in this feed show a clear long-tail: Syrah Resources’ $220M grant on 2022-10-20 is the largest disclosed amount, dwarfing the next tier (a number of rounds sit at $100M–$50M, including Applied Materials at $100M on 2022-10-19, Group14 Technologies at $100M on 2022-10-19, Microvast at $200M on 2022-10-19, and LanzaJet at $50M on 2022-10-19). Smaller disclosed rounds cluster around the $150K–$2M range, with multiple grants at $2M (e.g., Seneca College at $2M on 2022-10-26; PHARMAJET at $2M on 2022-10-24; Ventive at $2M on 2022-10-21).
Geographically and temporally, the page concentrates in a tight window: the most recent entry is 2022-10-26 (Cellular Logistics $340K; Seneca College $2M), while the oldest shown is 2022-10-17 (Qu Biologics Inc. $7M; Telescope Health $200K). Sector-wise, Biotechnology appears most frequently (3+ entries; e.g., Cellular Logistics $340K on 2022-10-26; PHARMAJET $2M on 2022-10-24; Day Zero Diagnostics $8M on 2022-10-20; IMMUNETHEP $3M on 2022-10-18). Uncertainty is also common: 12 of 50 rows list amounts as undisclosed, creating gaps in any cross-company comparisons.
Most recent rounds
50 shownRelated listings
Frequently asked
Which disclosed grant is the standout outlier, and what does that imply about deal size dispersion?
Syrah Resources’ $220M grant (2022-10-20) is far above the rest of the disclosed amounts on this page; the next-largest disclosed amounts are $200M for Microvast (2022-10-19) and $142M for Piedmont Lithium (2022-10-19), with many other grants clustered below $10M (e.g., Day Zero Diagnostics $8M on 2022-10-20; IMMUNETHEP $3M on 2022-10-18).
Are the grant dates clustered, or are they spread evenly across the page?
Dates are tightly clustered: the rows shown run from 2022-10-26 (Cellular Logistics $340K; Seneca College $2M) down to 2022-10-17 (Qu Biologics Inc. $7M; Telescope Health $200K). That 10-day window includes multiple high-value grants on consecutive dates like 2022-10-19 (Applied Materials $100M; Group14 Technologies $100M; Microvast $200M; Piedmont Lithium $142M; LanzaJet $50M).
Which sectors are over-represented in this grant listing?
Biotechnology is the most consistently repeated sector (at least 3 entries), including Cellular Logistics (Biotechnology, 2022-10-26, $340K), PHARMAJET (Biotechnology, 2022-10-24, $2M), Day Zero Diagnostics (Biotechnology, 2022-10-20, $8M), and IMMUNETHEP (Biotechnology, 2022-10-18, $3M). Other sectors appear but don’t show the same repetition pattern in the visible rows.
How complete are the disclosed amounts—are undisclosed grants a pattern or the exception?
Undisclosed amounts are relatively frequent: 12 out of 50 rows show “undisclosed” rather than a disclosed dollar value (e.g., DC4U on 2022-10-25; Alexandria Chamber of Commerce on 2022-10-24; ZiO Health on 2022-10-24; UCHealth on 2022-10-18). This makes comparisons of “largest” and “smallest” meaningful only within the subset that reports amounts.
Where do the smaller disclosed grants concentrate relative to the biggest rounds?
Beyond the top tier (Syrah Resources $220M; Microvast $200M; Applied Materials/Group14 Technologies each $100M on 2022-10-19), many disclosed grants sit in the low millions or below: Exceptional Minds is $1M on 2022-10-23 and Range Rehab is $20K on 2022-10-18 (the smallest disclosed amount on the page). This creates a clear split between a small number of very large awards and a long tail of smaller grants.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.